Skip to content
Trial Eligibility
Menu

Gut Mini-Pill Study

NCT07220369

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this proof-of-concept study in humans is to determine if a noninvasive, ingestible device, called a "mini-pill", can collect gastrointestinal (GI) luminal content samples from 2 different locations along the GI tract after consumption of diets differing in protein source (meat and plant-based meat alternatives). The mini-pills will be recovered in the stool. We will analyze the microbial profile of the mini-pill contents and in stool, and also measure blood biomarkers related to cardiometabolic risk, to better understand the relationship between diet, microbiota and health.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Gut Microbiota

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
50 to 75 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Tufts University
Last updated on ClinicalTrials.gov
October 30, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Jean Mayer Human Nutrition Research Center on Aging · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.